Cardlytics, Inc. Quarterly Costs and Expenses in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cardlytics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2017 to Q3 2024.
  • Cardlytics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $216M, a 116% increase year-over-year.
  • Cardlytics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $584M, a 18.7% decline year-over-year.
  • Cardlytics, Inc. annual Costs and Expenses for 2023 was $445M, a 41.2% decline from 2022.
  • Cardlytics, Inc. annual Costs and Expenses for 2022 was $756M, a 94.1% increase from 2021.
  • Cardlytics, Inc. annual Costs and Expenses for 2021 was $390M, a 61.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $584M $216M +$116M +116% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $468M $85.4M -$15.6M -15.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $483M $90.4M +$38.3M +73.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $445M $192M -$273M -58.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $718M $99.7M +$38.5M +62.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $679M $101M -$96.7M -48.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $776M $52.1M +$19.8M +61.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $756M $465M +$359M +337% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $398M $61.2M -$43.6M -41.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $441M $198M +$94.6M +91.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $347M $32.3M -$43.1M -57.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $390M $106M +$33.3M +45.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $356M $105M +$42.6M +68.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $314M $103M +$55.1M +115% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $259M $75.4M +$18M +31.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $241M $73.2M +$5.16M +7.59% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $236M $62.2M -$799K -1.27% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $236M $48M -$6.25M -11.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $243M $57.4M +$14.9M +35.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $228M $68M +$9.41M +16.1% Oct 1, 2019 Dec 31, 2019 10-K/A 2022-05-02
Q3 2019 $218M $63M +$19.8M +45.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $199M $54.2M +$7.01M +14.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $192M $42.5M -$41K -0.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $192M $58.6M +$17.2M +41.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $174M $43.2M +$9.3M +27.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $165M $47.2M +$9.08M +23.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $156M $42.5M +$8.6M +25.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $147M $41.5M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $33.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $38.1M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $33.9M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.